Home Cart Sign in  
Chemical Structure| 840506-29-8 Chemical Structure| 840506-29-8

Structure of Acelarin
CAS No.: 840506-29-8

Chemical Structure| 840506-29-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Acelarin is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine.

Synonyms: NUC-1031; CPF-31; GTPL7389

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Acelarin

CAS No. :840506-29-8
Formula : C25H27F2N4O8P
M.W : 580.47
SMILES Code : C[C@H](NP(OC1=CC=CC=C1)(OC[C@H]2O[C@@H](N3C=CC(N)=NC3=O)C(F)(F)[C@@H]2O)=O)C(OCC4=CC=CC=C4)=O
Synonyms :
NUC-1031; CPF-31; GTPL7389
MDL No. :MFCD27987942
InChI Key :NHTKGYOMICWFQZ-KKQYNPQSSA-N
Pubchem ID :11169170

Safety of Acelarin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Acelarin

DNA

Isoform Comparison

Biological Activity

Target
  • DNA synthesis

    DNA synthesis, EC50:0.2 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
A2780 cells 600 nM (IC50) 2 h To assess the kinetics of NUC-1031 cellular uptake and activation by analyzing intracellular levels of the active metabolite dFdCTP and its incorporation into DNA. Results showed that dFdCTP peaked at 48 hours post-treatment (350 nmol/10^6 cells). Transl Oncol. 2024 Dec;50:102114
HuCCT1 cells 1 μM (IC50) 24 h To assess the kinetics of NUC-1031 cellular uptake and activation by analyzing intracellular levels of the active metabolite dFdCTP and its incorporation into DNA. Results showed that dFdCTP peaked at 24 hours post-treatment (220 nmol/10^6 cells) and remained detectable up to 96 hours. Transl Oncol. 2024 Dec;50:102114
A2780 ovarian cancer cells 5 nM to 500 nM 2 h To evaluate the cytotoxic differences between NUC-1031 and gemcitabine on A2780 cells. Results showed that the cytotoxic effects of NUC-1031 were more prolonged than those of gemcitabine. Sci Rep. 2019 May 21;9(1):7643
MiaPaCa2 pancreatic cancer cells 5 nM to 250 nM 4 days To evaluate the cytotoxic differences between NUC-1031 and gemcitabine on MiaPaCa2 cells. Results showed that NUC-1031 retained cytotoxicity in the presence of deoxycytidine (dCyd), while gemcitabine was completely inactive. Sci Rep. 2019 May 21;9(1):7643

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01621854 Cancer PHASE1 COMPLETED 2025-06-15 NIHR/Wellcome Trust Imperial C... More >>RF, London, Hammersmith, W12 0HS, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.61mL

1.72mL

0.86mL

17.23mL

3.45mL

1.72mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories